{"ticker": {"uuid": "35d4670e-34bd-4253-bb17-51a7e7d88fcc", "symbol": "JBIO", "name": "Jade Biosciences, Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Price to sales forward of Jade Biosciences, Inc. \u2013 NASDAQ:JBIO", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQY1VGTmx2YzhTSnZsOHRSQlZtVzZFdTA2bEFXRUJzMHlXeGlQNnhId1pMOGZFLUN3UWltd2owTWMzWkhETzQxMTJxNnUwaXd6UHlqVFBCMTFkMVFLQmNsMV85enN6NGVJWm9Idm9wemp4bTlrNkEwdEVDdTN1enVnODhOZHM5UUQzendla3VYZVBnaHhBbTlVb3dZVEc4QQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T01:24:31+00:00", "published_display": "09 Jul 2026 01:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Jade Biosciences, Inc. (JBIO) Stock a Rising Biotech Opportunity in the $20B IgA Nephropathy Market?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/jade-biosciences-inc-jbio-stock-132113346.html", "source_name": "Insider Monkey", "published_at": "2026-06-30T13:21:13+00:00", "published_display": "30 Jun 2026 13:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immunology leader Mark Eisner joins Jade Biosciences (NASDAQ: JBIO) board", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOT2hkb0RjNGNKcjFjSlFScGoxOG9majJBd25CYUtMeHRacWUyNHAyaENHZkNnLUs0S0sxUnFyT2x0UG55WFpGRVpaSzlRTTZ4amNaWDBGNlFlWVdURVc1dkhWdUZvbEZTX212TS1sdk1qVktRc2dCakRoTDNtZGpiZm13S2F1cGxkeWdySDNEV3pfWFhXeGFvOXREWjFxZldEMFdXMVdWZURrOTFlb2c?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jade Biosciences, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPOHV3WEtCMFZZM0lqT3FJdWwxbjduWlhVOTdWSFJsUVlsLV9GemQ1cm51elp5Uy1DYnFHWEVRVmo2blExZEJFYU9lTVMyZ0tuWHZvTWxFcHJKRFJBRk9zR1U2dk1tUnd4MDFrd2psQ2l5aW5NQjMzYnkyNUszcHZNUW9lMDdteG5lMWRiZDE3UEp5NlVGdDVGNFlTZUtiTmRYckpYa2Z5QnEza3kyZE5sNWtubVk2VVhleEEzM3hGSXRzT2FwZjE5Qlo2RE1uaGloUnQwOExRSDBNSEpKQVE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jade Biosciences: Strong Early Signal, But Still A Wait For Proof (NASDAQ:JBIO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPaHRnR0xyd1lNaVJ2cmhXSXluakZyS0lSRE5IZVI2eFFFbG9GcEVLUEhmWEFRR0RXbnBuUHdFMVZDeHFOSEE0ZTlGRE9yaHhQN05obUZsbHpxQkp5V25mV1NRcjVHTFFlWGpKYlR2LWRsZ20tQjJlOHhLU1JmU1M1RXF4LXBwRE40bGdYUV9BbEJIMzE2ZmpIZTFPMEpOeFJPRURITXFmeFEzZXhv?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Jade Biosciences: Caution Advised Before Clinical Trial Results (NASDAQ:JBIO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPTlpsa2pzSVk2Z3p2ZHA1Zzh2UkU2aXpHSXo4bWZpNnlrS0E2YVJkUW5rNEtoaGJKVkE5Z1VPVFQ2LVF0ZlRsbEJzOFA2eENKaTdvUXk1X1YtekowLWxuQ1VLUFZBUEFsd19WaXdmNE9CaVAwV1poV2dtR05TTHRNZURoZ2ttZnBDam9Da3ctR0ttZzZGaC1zZXQ1bnRqazQ3a3BCTW9n?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Companies Like Jade Biosciences (NASDAQ:JBIO) Are In A Position To Invest In Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQeFo0Z08xX1duZWxpTEdCc3otWEpPTzVuc3ZWbTN6WnJYZERsT0ZuUmpZVUF5LXF2aDc4Sy11Qkl0dkJNZWZ2dFZJUGhIMkJuc1RKVzZ0dnhZdFo4VFpmVk16NzNOc2hBbUhsVHF1OUF1Tk9aQm9kZ0pwQmN2c2oyLTNpQlJUNmlJMmtJYklvSU03eGtQQm93WmRjR21YTUJVWTJQdVlR?oc=5", "source_name": "Market source", "published_at": "2026-03-28T07:00:00+00:00", "published_display": "28 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jade Biosciences, Inc. Common Stock (JBIO) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE14eVZOZ2RJMGNBV1FvQ01xdHNWdzAtMmt6VHlKT1pxajBXYmhlbDNucTFYZE5Vb0F3X1dKZ1pIMEVoQlZDZExmSnh2eGlnWjZwYVNVajRfMA?oc=5", "source_name": "Gotrade", "published_at": "2026-03-25T23:39:29+00:00", "published_display": "25 Mar 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The recent drop in prices must have disappointed Jade Biosciences, Inc. (NASDAQ:JBIO) institutional investors who own 53% of the shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQWnRfS0VlMHBFVHhKT0xWUTl0UzBEb3VlSExtdkJXeGl4TlItZzFBRU9XQmtjdnJHbWxrVTJqZjZyT0ZyX2xremhRQXN2ck9HaVJZeUdDQnBEMWRNUk0wNWZMaDhUR3VMRWh3bFhzT2VuOTBWQjlSNzl0UG8tdURDcTh3U1ZPTHI0bEtvNkNpQTFRUTFjdGZQbC0xT29xMXhnRXZvU3diblNUd3QwRDlzU0xCTWJLQXI3QzVPX19nbXVydjF5eXJjdFRCUHEtV1dLemJyckw0a2VUTEFFQURvQVpOejDSAeoBQVVfeXFMUGRZNEtadF9MYjlpWTJndXJzT2JEZ2J5MGl4amw5c2JzcmpoaVdNRlMwV2ptRjdGZTIyb2ZvZmgxU2gxN2xsUlhxdzMxeDAxQlpFY056bmdVNVNyN2otaUphRnp5aExwcnJDV2Rzb3E4NjlsVE1jSHduVWZRSHNhMWxIaVNpNTlhN0xNWjVqdG5UdWt5andQclFUNTlGR1hObDRpV2VCMnZyYm5tM2FmQk9YdjRyaWZhWjVJSHhES3RZR09pRlkwV0VxZ1VrQ3BzbnRRWFZFRkRGbVM0MlZXTzF3S21QV3hYSnJB?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-06T08:00:00+00:00", "published_display": "06 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Biotech Opportunities\u2019 Jade Biosciences merges with Aerovate Therapeutics", "summary": "Jade Biosciences, a portfolio company of RTW Biotech Opportunities (RTW), has merged with Nasdaq-listed Aerovate Therapeutics, with the combined entity retaining the Jade Biosciences name and JBIO ticker. This merger provides Jade Biosciences with a public listing and resources t", "url": "https://quoteddata.com/2025/04/rtw-biotech-opportunities-jade-biosciences-mergers-with-aerovate-therapeutics/", "source_name": "QuotedData", "published_at": "2025-04-30T09:09:26", "published_display": "30 Apr 2025 09:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JBIO Stock Price and Chart \u2014 NASDAQ:JBIO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9SbWxKdWxoNW5oMjFVZkNUeG9McHlpcVRVSERFdFB5Sm5jdExZUmNCMjJBOTUyOXpoRWQ4MDFDVy1EZU1heloxWk0zYkVGOHJzR3lNY05STkwweHJ4?oc=5", "source_name": "TradingView", "published_at": "2025-04-29T13:47:18+00:00", "published_display": "29 Apr 2025 13:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jade Biosciences Completes Closing of Merger with Aerovate", "summary": "Jade Biosciences announced the completion of its merger with Aerovate Therapeutics and an oversubscribed private investment round of approximately $300 million. The combined company, operating as Jade Biosciences, Inc., will trade on Nasdaq under \"JBIO\" and aims to advance best-i", "url": "https://www.globenewswire.com/news-release/2025/04/28/3069370/0/en/jade-biosciences-completes-closing-of-merger-with-aerovate-therapeutics-and-previously-announced-private-placement-of-approximately-300-million.html", "source_name": "GlobeNewswire", "published_at": "2025-04-28T18:09:53", "published_display": "28 Apr 2025 18:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aerovate Therapeutics and Jade Biosciences Merger Approved", "summary": "Aerovate Therapeutics announced stockholder approval for its merger with Jade Biosciences, including a 1-for-35 reverse stock split. The combined company will trade on Nasdaq as \"Jade Biosciences, Inc.\" (JBIO) starting April 29, 2025, with an estimated 32.2 million shares outstan", "url": "https://www.citybiz.co/article/684497/aerovate-therapeutics-and-jade-biosciences-merger-approved/", "source_name": "citybiz", "published_at": "2025-04-21T04:09:46", "published_display": "21 Apr 2025 04:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aerovate approves reverse split ahead of Jade merger By Investing.com", "summary": "Aerovate Therapeutics, Inc. announced a 1-for-35 reverse stock split ahead of its merger with Jade Biosciences, Inc., with the combined company set to trade as \"JBIO\" on Nasdaq from April 29, 2025. Stockholders will also receive a special cash dividend of an estimated $2.40 per s", "url": "https://ng.investing.com/news/company-news/aerovate-approves-reverse-split-ahead-of-jade-merger-93CH-1872984", "source_name": "Investing.com Nigeria", "published_at": "2025-04-21T02:09:26", "published_display": "21 Apr 2025 02:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aerovate Therapeutics Inc. (AVTE) reports earnings", "summary": "Aerovate Therapeutics Inc. (AVTE) filed its 10-K report for the fiscal year ended December 31, 2024, detailing a halt in the development of AV-101 due to negative clinical trial results. The company is undergoing restructuring and exploring a merger with Jade Biosciences, Inc., f", "url": "https://qz.com/aerovate-therapeutics-inc-avte-reports-earnings-1851772651", "source_name": "qz.com", "published_at": "2025-03-27T05:09:45", "published_display": "27 Mar 2025 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to sales forward of Jade Biosciences, Inc. \u2013 NASDAQ:JBIO", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQY1VGTmx2YzhTSnZsOHRSQlZtVzZFdTA2bEFXRUJzMHlXeGlQNnhId1pMOGZFLUN3UWltd2owTWMzWkhETzQxMTJxNnUwaXd6UHlqVFBCMTFkMVFLQmNsMV85enN6NGVJWm9Idm9wemp4bTlrNkEwdEVDdTN1enVnODhOZHM5UUQzendla3VYZVBnaHhBbTlVb3dZVEc4QQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T01:24:31+00:00", "published_display": "09 Jul 2026 01:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Jade Biosciences, Inc. (JBIO) Stock a Rising Biotech Opportunity in the $20B IgA Nephropathy Market?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/jade-biosciences-inc-jbio-stock-132113346.html", "source_name": "Insider Monkey", "published_at": "2026-06-30T13:21:13+00:00", "published_display": "30 Jun 2026 13:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immunology leader Mark Eisner joins Jade Biosciences (NASDAQ: JBIO) board", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOT2hkb0RjNGNKcjFjSlFScGoxOG9majJBd25CYUtMeHRacWUyNHAyaENHZkNnLUs0S0sxUnFyT2x0UG55WFpGRVpaSzlRTTZ4amNaWDBGNlFlWVdURVc1dkhWdUZvbEZTX212TS1sdk1qVktRc2dCakRoTDNtZGpiZm13S2F1cGxkeWdySDNEV3pfWFhXeGFvOXREWjFxZldEMFdXMVdWZURrOTFlb2c?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jade Biosciences, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPOHV3WEtCMFZZM0lqT3FJdWwxbjduWlhVOTdWSFJsUVlsLV9GemQ1cm51elp5Uy1DYnFHWEVRVmo2blExZEJFYU9lTVMyZ0tuWHZvTWxFcHJKRFJBRk9zR1U2dk1tUnd4MDFrd2psQ2l5aW5NQjMzYnkyNUszcHZNUW9lMDdteG5lMWRiZDE3UEp5NlVGdDVGNFlTZUtiTmRYckpYa2Z5QnEza3kyZE5sNWtubVk2VVhleEEzM3hGSXRzT2FwZjE5Qlo2RE1uaGloUnQwOExRSDBNSEpKQVE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jade Biosciences: Strong Early Signal, But Still A Wait For Proof (NASDAQ:JBIO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPaHRnR0xyd1lNaVJ2cmhXSXluakZyS0lSRE5IZVI2eFFFbG9GcEVLUEhmWEFRR0RXbnBuUHdFMVZDeHFOSEE0ZTlGRE9yaHhQN05obUZsbHpxQkp5V25mV1NRcjVHTFFlWGpKYlR2LWRsZ20tQjJlOHhLU1JmU1M1RXF4LXBwRE40bGdYUV9BbEJIMzE2ZmpIZTFPMEpOeFJPRURITXFmeFEzZXhv?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jade Biosciences: Caution Advised Before Clinical Trial Results (NASDAQ:JBIO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPTlpsa2pzSVk2Z3p2ZHA1Zzh2UkU2aXpHSXo4bWZpNnlrS0E2YVJkUW5rNEtoaGJKVkE5Z1VPVFQ2LVF0ZlRsbEJzOFA2eENKaTdvUXk1X1YtekowLWxuQ1VLUFZBUEFsd19WaXdmNE9CaVAwV1poV2dtR05TTHRNZURoZ2ttZnBDam9Da3ctR0ttZzZGaC1zZXQ1bnRqazQ3a3BCTW9n?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Companies Like Jade Biosciences (NASDAQ:JBIO) Are In A Position To Invest In Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQeFo0Z08xX1duZWxpTEdCc3otWEpPTzVuc3ZWbTN6WnJYZERsT0ZuUmpZVUF5LXF2aDc4Sy11Qkl0dkJNZWZ2dFZJUGhIMkJuc1RKVzZ0dnhZdFo4VFpmVk16NzNOc2hBbUhsVHF1OUF1Tk9aQm9kZ0pwQmN2c2oyLTNpQlJUNmlJMmtJYklvSU03eGtQQm93WmRjR21YTUJVWTJQdVlR?oc=5", "source_name": "Market source", "published_at": "2026-03-28T07:00:00+00:00", "published_display": "28 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jade Biosciences, Inc. Common Stock (JBIO) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE14eVZOZ2RJMGNBV1FvQ01xdHNWdzAtMmt6VHlKT1pxajBXYmhlbDNucTFYZE5Vb0F3X1dKZ1pIMEVoQlZDZExmSnh2eGlnWjZwYVNVajRfMA?oc=5", "source_name": "Gotrade", "published_at": "2026-03-25T23:39:29+00:00", "published_display": "25 Mar 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The recent drop in prices must have disappointed Jade Biosciences, Inc. (NASDAQ:JBIO) institutional investors who own 53% of the shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-06T08:00:00+00:00", "published_display": "06 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RTW Biotech Opportunities\u2019 Jade Biosciences merges with Aerovate Therapeutics", "summary": "Jade Biosciences, a portfolio company of RTW Biotech Opportunities (RTW), has merged with Nasdaq-listed Aerovate Therapeutics, with the combined entity retaining the Jade Biosciences name and JBIO ticker. This merger provides Jade Biosciences with a public listing and resources t", "url": "https://quoteddata.com/2025/04/rtw-biotech-opportunities-jade-biosciences-mergers-with-aerovate-therapeutics/", "source_name": "QuotedData", "published_at": "2025-04-30T09:09:26", "published_display": "30 Apr 2025 09:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JBIO Stock Price and Chart \u2014 NASDAQ:JBIO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9SbWxKdWxoNW5oMjFVZkNUeG9McHlpcVRVSERFdFB5Sm5jdExZUmNCMjJBOTUyOXpoRWQ4MDFDVy1EZU1heloxWk0zYkVGOHJzR3lNY05STkwweHJ4?oc=5", "source_name": "TradingView", "published_at": "2025-04-29T13:47:18+00:00", "published_display": "29 Apr 2025 13:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jade Biosciences Completes Closing of Merger with Aerovate", "summary": "Jade Biosciences announced the completion of its merger with Aerovate Therapeutics and an oversubscribed private investment round of approximately $300 million. The combined company, operating as Jade Biosciences, Inc., will trade on Nasdaq under \"JBIO\" and aims to advance best-i", "url": "https://www.globenewswire.com/news-release/2025/04/28/3069370/0/en/jade-biosciences-completes-closing-of-merger-with-aerovate-therapeutics-and-previously-announced-private-placement-of-approximately-300-million.html", "source_name": "GlobeNewswire", "published_at": "2025-04-28T18:09:53", "published_display": "28 Apr 2025 18:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aerovate Therapeutics and Jade Biosciences Merger Approved", "summary": "Aerovate Therapeutics announced stockholder approval for its merger with Jade Biosciences, including a 1-for-35 reverse stock split. The combined company will trade on Nasdaq as \"Jade Biosciences, Inc.\" (JBIO) starting April 29, 2025, with an estimated 32.2 million shares outstan", "url": "https://www.citybiz.co/article/684497/aerovate-therapeutics-and-jade-biosciences-merger-approved/", "source_name": "citybiz", "published_at": "2025-04-21T04:09:46", "published_display": "21 Apr 2025 04:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aerovate approves reverse split ahead of Jade merger By Investing.com", "summary": "Aerovate Therapeutics, Inc. announced a 1-for-35 reverse stock split ahead of its merger with Jade Biosciences, Inc., with the combined company set to trade as \"JBIO\" on Nasdaq from April 29, 2025. Stockholders will also receive a special cash dividend of an estimated $2.40 per s", "url": "https://ng.investing.com/news/company-news/aerovate-approves-reverse-split-ahead-of-jade-merger-93CH-1872984", "source_name": "Investing.com Nigeria", "published_at": "2025-04-21T02:09:26", "published_display": "21 Apr 2025 02:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aerovate Therapeutics Inc. (AVTE) reports earnings", "summary": "Aerovate Therapeutics Inc. (AVTE) filed its 10-K report for the fiscal year ended December 31, 2024, detailing a halt in the development of AV-101 due to negative clinical trial results. The company is undergoing restructuring and exploring a merger with Jade Biosciences, Inc., f", "url": "https://qz.com/aerovate-therapeutics-inc-avte-reports-earnings-1851772651", "source_name": "qz.com", "published_at": "2025-03-27T05:09:45", "published_display": "27 Mar 2025 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 101, "total_relevant": 24, "sentiment_summary": {"positive": 7, "negative": 1, "neutral": 16, "score": 57, "total": 24, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 5.3, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 4.61, "count": 10}, {"event": "deals", "label": "Deals and strategy", "weight": 2.75, "count": 5}], "positive_events": 7, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 20.86, "latest_week": "2026-07-17", "one_week_move": -0.4, "four_week_move": 24.0, "twelve_week_move": -16.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.003551, "market_dynamics_buy_signal": false, "relative_strength": 32.11186, "fair_value_gap": -88.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 46.9631, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.4% over one week, +24.0% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 7}, {"label": "TradingView", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "Seeking Alpha", "count": 2}, {"label": "Insider Monkey", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Quiver Quantitative", "count": 1}, {"label": "Gotrade", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 10}, {"label": "Market update", "count": 9}, {"label": "Deals and strategy", "count": 5}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-0.4% over one week, +24.0% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to sales forward of Jade Biosciences, Inc. \u2013 NASDAQ:JBIO"}], "updated_at": "2026-07-22T13:37:03.873140+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}